Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page
- Check4 days agoChange DetectedAdded user-help sections: How to Read a Study Record, Common Questions, How to Join a Study, and a formatting update for Intervention/Treatment. Release notes were updated to Revision: v3.6.0.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page revision stamp changed from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to reflect an update to the page's version rather than a substantive content change.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision label was updated from v3.5.3 to v3.5.4, representing a newer documented version of the page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows a new revision label (v3.5.3), replacing the previous v3.5.2 to indicate a fresh revision of the page content.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0, updating the page’s version information.SummaryDifference0.1%

- Check90 days agoChange DetectedA newer revision, v3.5.0, was added and the older revision, v3.4.3, was removed.SummaryDifference0.1%

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.